TY - JOUR
T1 - Atypical mycobacterium keratitis associated with penetrating keratoplasty: Case report of successful therapy with topical gatifloxacin 0.3%
AU - Perez-Balbuena, Ana Lilia
AU - Vanzzini-Zago, Virginia
AU - Garza, Manuel
AU - Cancino, Diego Cuevas
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Purpose: To report successful therapy with gatifloxacin 0.3% ophthalmic solution (Zymar) in a patient with atypical mycobacterium keratitis after penetrating keratoplasty. Methods: A 58-year-old patient was referred for evaluation of microbial keratitis after penetrating keratoplasty. Results: Clinical examination of the patient revealed an infiltrate at the inferior graft-host junction with a satellite lesion with a mild inflammatory reaction in the anterior chamber. Microbiologic evaluation confirmed the diagnosis of atypical mycobacteria keratitis. The corneal abscess was completely eradicated with a topical course of gatifloxacin 0.3% with preservation of graft clarity and good visual acuity. Topical treatment with gatifloxacin 0.3% was continued for an additional period of 5 months. Conclusion: Topical gatifloxacin 0.3% may be successfully used to treat microbial keratitis resulting from atypical mycobacteria.
AB - Purpose: To report successful therapy with gatifloxacin 0.3% ophthalmic solution (Zymar) in a patient with atypical mycobacterium keratitis after penetrating keratoplasty. Methods: A 58-year-old patient was referred for evaluation of microbial keratitis after penetrating keratoplasty. Results: Clinical examination of the patient revealed an infiltrate at the inferior graft-host junction with a satellite lesion with a mild inflammatory reaction in the anterior chamber. Microbiologic evaluation confirmed the diagnosis of atypical mycobacteria keratitis. The corneal abscess was completely eradicated with a topical course of gatifloxacin 0.3% with preservation of graft clarity and good visual acuity. Topical treatment with gatifloxacin 0.3% was continued for an additional period of 5 months. Conclusion: Topical gatifloxacin 0.3% may be successfully used to treat microbial keratitis resulting from atypical mycobacteria.
UR - http://www.scopus.com/inward/record.url?scp=77957359958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957359958&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/fc117103-f37b-3664-b642-5a5fe0a02d8e/
U2 - 10.1097/ICO.0b013e3181b532c7
DO - 10.1097/ICO.0b013e3181b532c7
M3 - Article
SN - 0277-3740
VL - 29
SP - 468
EP - 470
JO - Cornea
JF - Cornea
IS - 4
ER -